Promising therapy for relapsing multiple sclerosis
Tuesday, February 16, 2010 - 15:07
in Health & Medicine
Scientists have found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis.